XJPX4931
Market cap262mUSD
Jan 22, Last price
1,906.00JPY
1D
0.11%
1Q
11.66%
IPO
22.81%
Name
Shinnihonseiyaku Co Ltd
Chart & Performance
Profile
Shinnihonseiyaku Co., Ltd. provides cosmetics, pharmaceuticals, and health foods in Japan and internationally. It operates through Mail Order, Direct Store Sales/Wholesale, and Overseas Sales segments. The company provides skincare products under the Perfect One and Perfect One Focus brands; and pharmaceutical products for various diseases and symptoms. It operates a network of eight direct stores; NOIN, a cosmetics mail order app; and online shops. The company was formerly known as Shinnihonliving Co., Ltd. and changed its name to Shinnihonseiyaku Co., Ltd. in April 2002. The company was incorporated in 1992 and is headquartered in Fukuoka City, Japan.
IPO date
Jun 27, 2019
Employees
302
Domiciled in
JP
Incorporated in
JP
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|
2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
Income | |||||||
Revenues | 37,653,000 4.28% | 36,107,000 6.52% | |||||
Cost of revenue | 33,670,000 | 32,260,000 | |||||
Unusual Expense (Income) | |||||||
NOPBT | 3,983,000 | 3,847,000 | |||||
NOPBT Margin | 10.58% | 10.65% | |||||
Operating Taxes | 1,135,000 | 1,117,000 | |||||
Tax Rate | 28.50% | 29.04% | |||||
NOPAT | 2,848,000 | 2,730,000 | |||||
Net income | 2,394,000 1.57% | 2,357,000 1.46% | |||||
Dividends | (708,000) | (695,000) | |||||
Dividend yield | 2.14% | 2.14% | |||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
Debt | |||||||
Debt current | 192,000 | 396,000 | |||||
Long-term debt | 254,000 | 1,443,000 | |||||
Deferred revenue | |||||||
Other long-term liabilities | 504,000 | 522,000 | |||||
Net debt | (15,253,000) | (12,904,000) | |||||
Cash flow | |||||||
Cash from operating activities | 3,468,000 | 2,287,000 | |||||
CAPEX | (102,000) | (378,000) | |||||
Cash from investing activities | (208,000) | (496,000) | |||||
Cash from financing activities | (2,101,000) | (1,093,000) | |||||
FCF | 2,651,000 | 2,064,000 | |||||
Balance | |||||||
Cash | 15,518,000 | 14,351,000 | |||||
Long term investments | 181,000 | 392,000 | |||||
Excess cash | 13,816,350 | 12,937,650 | |||||
Stockholders' equity | 16,043,000 | 14,531,000 | |||||
Invested Capital | 6,793,650 | 6,840,350 | |||||
ROIC | 41.78% | 43.19% | |||||
ROCE | 19.33% | 19.45% | |||||
EV | |||||||
Common stock shares outstanding | 21,607 | 21,601 | |||||
Price | 1,528.00 1.73% | 1,502.00 -20.40% | |||||
Market cap | 33,016,148 1.76% | 32,444,172 -21.06% | |||||
EV | 17,763,148 | 19,540,172 | |||||
EBITDA | 4,416,000 | 4,275,000 | |||||
EV/EBITDA | 4.02 | 4.57 | |||||
Interest | 3,000 | 5,000 | |||||
Interest/NOPBT | 0.08% | 0.13% |